LPCAT3 as a Potential Drug Target for Ultraviolet Radiation-Induced Cataract: Insights From Multiomics Analysis

Fei Xu1,2, Xiao-Bo Wan2, Yong-Shun Liang1

  • 1Department of Ophthalmology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Insights

UVB radiation causes cataracts by inducing ferroptosis in lens cells. Upregulation of LPCAT3 drives this process, and targeting LPCAT3 shows therapeutic potential for preventing cataracts.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Biochemistry

Background:

  • Ultraviolet B (UVB) radiation is a known risk factor for cataract development.
  • The precise molecular mechanisms, especially the role of regulated cell death like ferroptosis, are not fully understood.

Purpose of the Study:

  • To investigate the molecular mechanisms of UVB-induced cataract formation, focusing on ferroptosis.
  • To identify key genes, proteins, and metabolites involved in cataractogenesis.
  • To evaluate the therapeutic potential of targeting lysophosphatidylcholine acyltransferase 3 (LPCAT3).

Main Methods:

  • Multiomics analyses (transcriptomic, proteomic, metabolomic) on rat models of UVB-induced cataracts.
  • Bioinformatic integration to identify key molecular pathways and candidates.
  • In vitro studies on rat lens epithelial cells (LECs) and in vivo studies using an Ad5-shLPCAT3 knockdown model.

Main Results:

  • Identified significant differentially expressed genes, proteins, and metabolites, highlighting glycerophospholipid metabolism.
  • Found LPCAT3 significantly upregulated in cataractous lenses and UVB-irradiated LECs.
  • Demonstrated that UVB induces ferroptosis in LECs, characterized by specific molecular markers.
  • Showed that LPCAT3 knockdown protected LECs from UVB-induced ferroptosis and that in vivo knockdown attenuated cataract formation.

Conclusions:

  • LPCAT3 upregulation is a key driver of UVB-induced ferroptosis in lens epithelial cells.
  • Targeting LPCAT3 effectively mitigates UVB-induced ferroptosis and cataract formation.
  • LPCAT3 represents a promising therapeutic target for preventing UVB-induced cataracts.